AFP and hepatocellular carcinoma: For the main guidelines analysis, we estimated the health benefits and economic impacts of 6-monthly HCC surveillance with US, with or without AFP testing, versus no routine HCC surveillance as the comparator (status quo for people with cirrhosis in Australia15).